•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Hologic (HOLX) Suffers a Larger Drop Than the General Market: Key Insights
Hologic's Margin Stability Amid Tariffs: What's Behind the Confidence?
Can Hologic Lean on Its Strengths in a Tough Macroeconomic Climate?
Investors Heavily Search Hologic, Inc. (HOLX): Here is What You Need to Know
Hologic Climbs 13% in a Month: How Should You Play the Stock?
Hologic Navigates Breast Health Slump: Is the Growth Thesis Intact?
Hologic Joins NEST Governance Committee to Advance the Use of Real-World Data in Medical Device Evaluation
Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock
Why Is Diagnostic Firm Hologic Stock Trading Higher On Tuesday?
Hologic reportedly rejects $16B go-private offer from TPG, Blackstone
Hologic rejects $16 billion take-private proposal from TPG and Blackstone, Financial Times reports
HOLX vs. DGX: Which Women's Health-Focused Stock Is the Better Pick?
Hologic to Present New Data at ASCO 2025 Reinforcing the Practice-Changing Role of the Breast Cancer Index® Test in Helping to Deliver More Personalized Care to Patients
Is Trending Stock Hologic, Inc. (HOLX) a Buy Now?
Hologic to Webcast Presentations at Upcoming Investor Conferences
Understanding Hologic (HOLX) Reliance on International Revenue
Tariffs Dim Hologic's 2025 Expectations: Time to Reassess the Stock?
Hologic: Soft Performance, But Cheap Enough
Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know
Hologic Q2 Earnings & Revenues Top, '25 EPS View Lowered, Stock Down
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.